Trial intelligence / Profile preview

Neoadjuvant Chemotherapy and Surgery With or Without Radiotherapy in MPM

NCT00334594Phase 2Completed

Sponsor
Swiss Group for Clinical Cancer Research
Start
Nov 2005
Primary completion
Mar 2014
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of cisplatin, pemetrexed in malignant pleural mesothelioma (MPM), sponsored by Swiss Group for Clinical Cancer Research. Started Nov 2005; status: completed.

02

Drugs

cisplatinpemetrexed
03

Conditions

malignant pleural mesothelioma (MPM)

Beyond the preview

Go deeper on NCT00334594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00334594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call